Get the Stockscreener App
9.8149
1.32%
-0.1251
Organon Co stock is traded at $9.8149, with a volume of 1.06M.
It is down -1.32% in the last 24 hours and down -2.30% over the past month.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
See More
Previous Close:
$9.94
Open:
$9.9
24h Volume:
1.06M
Relative Volume:
0.19
Market Cap:
$2.55B
Revenue:
$6.29B
Net Income/Loss:
$750.00M
P/E Ratio:
3.408
EPS:
2.88
Net Cash Flow:
$586.00M
1W Performance:
+0.91%
1M Performance:
-2.30%
6M Performance:
-37.96%
1Y Performance:
-53.95%
1-Day Range:
$9.765
$10.01
1-Week Range:
$9.71
$10.27
52-Week Range:
$8.01
$23.10
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.815 | 2.53B | 6.29B | 750.00M | 586.00M | 2.88 |
|
LLY
Lilly Eli Co
|
797.95 | 693.83B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
156.11 | 373.59B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
190.84 | 331.43B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
120.95 | 241.20B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
69.16 | 308.01B | 43.59B | 15.04B | 10.74B | 3.3766 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming DeadlinesOGN - FinancialContent
ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein - GlobeNewswire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Teacher Retirement System of Texas Decreases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
Organon & Co. (OGN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 22, 2025 - Stockhouse
OGN IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action – OGN - TradingView
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Organon & Co. (OGN) Investors of July 22, 2025 Deadline - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Organon, UroGen and Fortrea and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
OGN FRAUD ALERT: Organon & Co. 27% Stock Drop Triggers - GlobeNewswire
Organon & Co. Sued for Securities Law Violations – - GlobeNewswire
Organon & Co.'s VTAMA Cream: A Breakthrough in Atopic Dermatitis and a Growth Catalyst for OGN - AInvest
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Act Now or Risk Losses: Organon Investors Face Critical July 22 Deadline in Securities Fraud Lawsuit - AInvest
Deadline Alert: Organon & Co. (OGN) Investors Who Lost - GlobeNewswire
Organon & Co. (OGN) Announces American Academy of Dermatology’s Strong Recommendation for VTAMA Cream - Insider Monkey
Organon & Co. Securities Fraud Class Action Lawsuit - GlobeNewswire
Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Organon & Co.OGN - GlobeNewswire
Organon & Co. Investors: Please contact the Portnoy Law - GlobeNewswire
Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance
Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
OGN Shareholders Have the Right to Lead the Organon & Co. Securities LawsuitContact the DJS Law Group to Discuss Your RightsOGN - Morningstar
With 79% ownership of the shares, Organon & Co. (NYSE:OGN) is heavily dominated by institutional owners - Yahoo Finance
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - TradingView
ROSEN, A RANKED AND LEADING FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming DeadlinesOGN - TradingView
July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire
Yousif Capital Management LLC Cuts Position in Organon & Co. (NYSE:OGN) - Defense World
Organon: A Look Beyond The Dividend Cut (NYSE:OGN) - Seeking Alpha
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire
Investors who lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class ActionOGN - PR Newswire
Organon: Persistent Headwinds Make This A Hold - Seeking Alpha
Investor Alert: Deadline Approaching to Join Organon & Co. (OGN) Class ActionContact Levi & Korsinsky - ACCESS Newswire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - PR Newswire
Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Class Action Filed Against Organon & Co. (OGN)July 22, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
OGN SHAREHOLDER REPORT: Organon & Co. was Sued for Fraud – - GlobeNewswire
Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire
Class Action Lawsuit Filed Against Organon & Co. (OGN)Recover LossesContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
Investors in Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your RightsOGN - WV News
Securities Class Action Lawsuit Filed Against Organon & Co. (OGN)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Securities Lawsuit Alert: Organon & Co. (OGN) InvestorsContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire
ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
Lost Money on Organon & Co. (OGN)? Join Class Action Before July 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
OGN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Organon & Co.July 22, 2025 Deadline - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - StreetInsider
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organon Co Stock (OGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Falcione Aaron | Chief Human Resources Officer |
May 07 '25 |
Buy |
8.77 |
5,500 |
48,235 |
62,974 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. |
May 06 '25 |
Buy |
9.21 |
8,045 |
74,054 |
52,489 |
| Karp Daniel | Executive VP, Corp. Dev. |
May 06 '25 |
Buy |
8.24 |
3,500 |
28,828 |
46,669 |
| WALSH MATTHEW M | Chief Financial Officer |
May 05 '25 |
Buy |
8.82 |
11,400 |
100,548 |
144,484 |
| Ali Kevin | Chief Executive Officer |
May 05 '25 |
Buy |
8.80 |
34,000 |
299,370 |
282,731 |
| Falcione Aaron | Chief Human Resources Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,732 |
0 |
59,237 |
| Karp Daniel | Executive VP, Corp. Dev. |
Mar 31 '25 |
Option Exercise |
0.00 |
34,677 |
0 |
44,515 |
| Stahler Rachel A | Chief Information Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,334 |
0 |
78,994 |
| WALSH MATTHEW M | Chief Financial Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
34,870 |
0 |
136,903 |
| Arjona Ferreira Juan Camilo | Head of R&D & CMO |
Mar 31 '25 |
Option Exercise |
0.00 |
8,865 |
0 |
20,552 |
0.07%
2.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):